Country

Clinical trials in Serbia

Active obesity and GLP-1 studies with at least one location in Serbia.

3active studies

2recruiting now

6countries represented

36largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 3

Overweight, ObesityCondition

Cagrilintide, Placebo cagrilintideTreatment

Greece, Hungary36 locations

Novo Nordisk A/SSponsor

Updated 2026-09-04 · NCT07745504See eligibility →

Recruiting nowPhase 2

Obesity, Muscle LossCondition

(S)-pindolol benzoate, SemaglutideTreatment

Serbia7 locations

Actimed Therapeutics LtdSponsor

Updated 2026-02-17 · NCT07101939See eligibility →

Opening soonNot applicable

OverweightCondition

Hydrogen-rich water, ControlTreatment

Serbia1 locations

Center for Health Sciences, SerbiaSponsor

Updated 2026-02-13 · NCT07410065See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.